• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

个性化医疗时代的生物样本库:目标、挑战与创新:概述

Biobanks in the era of personalized medicine: objectives, challenges, and innovation: Overview.

作者信息

Kinkorová Judita

机构信息

Faculty Hospital in Pilsen, Edvarda Benese 1128/13, 305 99 Plzen, Czech Republic ; Medical Faculty Charles University in Pilsen, Lidicka 1, 301 00 Plzen, Czech Republic.

出版信息

EPMA J. 2016 Feb 22;7(1):4. doi: 10.1186/s13167-016-0053-7. eCollection 2015.

DOI:10.1186/s13167-016-0053-7
PMID:26904153
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4762166/
Abstract

Biobanks are an important compound of personalized medicine and strongly support the scientific progress in stratification of population and biomarker discovery and validation due to progress in personalized medicine. Biobanks are an essential tool for new drug discoveries and drug development. Biobanks play an important role in the whole process of patient prevention and prediction, follow-up, and therapy monitoring and optimalization. Biobanks have the specificity in that they cover multidisciplinary approach to the human health combining biological and medical approaches, as well as informative bioinformatics technologies, computationing, and modeling. The importance of biobanks has during the last decade increased in variety and capacity from small collections of samples to large-scale national or international repositories. Collected samples are population-based, disease-specific or rare diseases originating from a diverse profile of individuals. There are various purposes of biobanks, such as diagnostics, pharmacology, or research. Biobanks involve, store, and operate with specific personal information, and as a consequence, such a diversity of biobanking is associated with a broad spectrum of ethical and legal issues. Biobanks are an international phenomenon because any single country, state, or society at the moment is not able to cover all issues involving the whole biobank problematic. Biobanks have an enormous innovative potential in the whole process of biomedical research in the twenty-first century.

摘要

生物样本库是个性化医疗的重要组成部分,由于个性化医疗的发展,有力地支持了人群分层以及生物标志物发现与验证方面的科学进展。生物样本库是新药研发和药物开发的重要工具。生物样本库在患者预防、预测、随访以及治疗监测与优化的全过程中发挥着重要作用。生物样本库具有特殊性,因为它们涵盖了结合生物学和医学方法以及信息丰富的生物信息学技术、计算和建模的多学科人类健康研究方法。在过去十年中,生物样本库的重要性在种类和容量上都有所增加,从少量样本收集发展到大规模的国家或国际储存库。收集的样本以人群为基础,包括特定疾病或罕见疾病的样本,来源广泛。生物样本库有多种用途,如诊断、药理学或研究。生物样本库涉及、存储并处理特定的个人信息,因此,这种多样的生物样本库与广泛的伦理和法律问题相关联。生物样本库是一种国际现象,因为目前任何一个国家、州或社会都无法涵盖涉及整个生物样本库问题的所有方面。在21世纪的生物医学研究全过程中,生物样本库具有巨大的创新潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdd7/4762166/b805515176f2/13167_2016_53_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdd7/4762166/784e5ea0322b/13167_2016_53_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdd7/4762166/4a6d70db4f27/13167_2016_53_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdd7/4762166/55a242c994c4/13167_2016_53_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdd7/4762166/b805515176f2/13167_2016_53_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdd7/4762166/784e5ea0322b/13167_2016_53_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdd7/4762166/4a6d70db4f27/13167_2016_53_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdd7/4762166/55a242c994c4/13167_2016_53_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdd7/4762166/b805515176f2/13167_2016_53_Fig5_HTML.jpg

相似文献

1
Biobanks in the era of personalized medicine: objectives, challenges, and innovation: Overview.个性化医疗时代的生物样本库:目标、挑战与创新:概述
EPMA J. 2016 Feb 22;7(1):4. doi: 10.1186/s13167-016-0053-7. eCollection 2015.
2
Biobanks in Horizon 2020: sustainability and attractive perspectives.“地平线2020”中的生物样本库:可持续性与诱人前景。
EPMA J. 2018 Nov 23;9(4):345-353. doi: 10.1007/s13167-018-0153-7. eCollection 2018 Dec.
3
Biobanking in health care: evolution and future directions.生物银行在医疗保健中的应用:发展与未来方向。
J Transl Med. 2019 May 22;17(1):172. doi: 10.1186/s12967-019-1922-3.
4
The landscape of biobanks in Poland-characteristics of Polish biobanking units at the beginning of BBMRI.pl organization.波兰生物银行的格局——BBMRI.pl 组织成立之初的波兰生物银行单位的特点。
J Transl Med. 2021 Jun 22;19(1):267. doi: 10.1186/s12967-021-02926-y.
5
Biobanks and Their Clinical Application and Informatics Challenges.生物样本库及其临床应用与信息学挑战。
Adv Exp Med Biol. 2016;939:241-257. doi: 10.1007/978-981-10-1503-8_10.
6
To donate or not to donate? Future healthcare professionals' opinions on biobanking of human biological material for research purposes.是否捐赠?未来医疗保健专业人员对人类生物材料用于研究目的的生物库的看法。
BMC Med Ethics. 2023 Jul 22;24(1):53. doi: 10.1186/s12910-023-00930-z.
7
Pediatric biobanks to enhance clinical and translational research for children.儿科生物库助力儿童临床和转化研究。
Eur J Pediatr. 2023 Apr;182(4):1459-1468. doi: 10.1007/s00431-023-04818-3. Epub 2023 Jan 24.
8
Education for future biobankers - The state-of-the-art and outlook.面向未来生物样本库从业者的教育——现状与展望。
EPMA J. 2021 Mar 10;12(1):15-25. doi: 10.1007/s13167-021-00234-5. eCollection 2021 Mar.
9
Current aspects in biobanking for personalized oncology investigations and treatments.个性化肿瘤学研究与治疗生物样本库的当前进展
Med Pharm Rep. 2023 Jul;96(3):235-245. doi: 10.15386/mpr-2647. Epub 2023 Jul 27.
10
Current status, challenges, policies, and bioethics of biobanks.生物样本库的现状、挑战、政策及生物伦理
Genomics Inform. 2013 Dec;11(4):211-7. doi: 10.5808/GI.2013.11.4.211. Epub 2013 Dec 31.

引用本文的文献

1
Quantifying the impact of biobanks and cohort studies.量化生物样本库和队列研究的影响。
Proc Natl Acad Sci U S A. 2025 Apr 22;122(16):e2427157122. doi: 10.1073/pnas.2427157122. Epub 2025 Apr 16.
2
Decentralized Biobanking Apps for Patient Tracking of Biospecimen Research: Real-World Usability and Feasibility Study.用于生物样本研究患者追踪的去中心化生物样本库应用程序:真实世界的可用性和可行性研究。
JMIR Bioinform Biotechnol. 2025 Apr 10;6:e70463. doi: 10.2196/70463.
3
A roadmap to precision medicine through post-genomic electronic medical records.

本文引用的文献

1
Toward the integration of personalized and systems medicine: challenges, opportunities and approaches.迈向个性化医学与系统医学的整合:挑战、机遇与方法
Per Med. 2011 Jan;8(1):1-4. doi: 10.2217/pme.10.77.
2
EPMA summit 2014 under the auspices of the presidency of Italy in the EU: professional statements.2014年在意大利担任欧盟轮值主席国期间举办的电子探针微量分析峰会:专业声明。
EPMA J. 2015 Feb 24;6(1):4. doi: 10.1186/s13167-015-0026-2. eCollection 2015.
3
The EuroBioBank Network: 10 years of hands-on experience of collaborative, transnational biobanking for rare diseases.
通过基因组后电子病历实现精准医疗的路线图。
Nat Commun. 2025 Feb 17;16(1):1700. doi: 10.1038/s41467-025-56442-4.
4
Assessment of biobank awareness among medical students in Iran.伊朗医学生对生物样本库的认知评估。
J Community Genet. 2025 Apr;16(2):183-193. doi: 10.1007/s12687-025-00769-4. Epub 2025 Jan 21.
5
Body mass index trajectories may represent modifiable targets in the promotion of respiratory health.体重指数轨迹可能是促进呼吸健康方面可改变的目标。
Eur Respir J. 2025 Jan 2;65(1). doi: 10.1183/13993003.02061-2024. Print 2025 Jan.
6
Biobanks and data interoperability in Latin America: engendering high-quality evidence for the global research ecosystem.拉丁美洲的生物样本库与数据互操作性:为全球研究生态系统提供高质量证据。
Front Med (Lausanne). 2024 Dec 16;11:1481891. doi: 10.3389/fmed.2024.1481891. eCollection 2024.
7
What public health challenges and unmet medical needs would benefit from interdisciplinary collaboration in the EU? A survey and multi-stakeholder debate.在欧盟,哪些公共卫生挑战和未满足的医疗需求将受益于跨学科合作?一项调查和多方利益相关者的辩论。
Front Public Health. 2024 Jul 22;12:1417684. doi: 10.3389/fpubh.2024.1417684. eCollection 2024.
8
LUNGBANK: a novel biorepository strategy tailored for comprehensive multiomics analysis and P-medicine applications in lung cancer.肺库:一种专为肺癌的全面多组学分析和精准医学应用量身定制的新型生物样本库策略。
Turk J Biol. 2024 May 28;48(3):203-217. doi: 10.55730/1300-0152.2696. eCollection 2024.
9
Whole genome sequencing in (recurrent) glioblastoma: challenges related to informed consent procedures and data sharing.全基因组测序在(复发性)脑胶质瘤中的应用:与知情同意程序和数据共享相关的挑战。
Acta Neurochir (Wien). 2024 Jun 14;166(1):266. doi: 10.1007/s00701-024-06158-z.
10
Implementation of a roadmap for the comprehensive diagnosis, follow-up, and research of childhood leukemias in vulnerable regions of Mexico: results from the PRONAII Strategy.墨西哥脆弱地区儿童白血病综合诊断、随访及研究路线图的实施:PRONAII 战略的成果
Front Oncol. 2024 Apr 3;14:1304690. doi: 10.3389/fonc.2024.1304690. eCollection 2024.
欧洲生物样本库网络:10年罕见病协作式跨国生物样本库实践经验
Eur J Hum Genet. 2015 Sep;23(9):1116-23. doi: 10.1038/ejhg.2014.272. Epub 2014 Dec 24.
4
2012 best practices for repositories collection, storage, retrieval, and distribution of biological materials for research international society for biological and environmental repositories.2012年生物材料用于研究的储存库收集、存储、检索和分发最佳实践 国际生物与环境储存库协会
Biopreserv Biobank. 2012 Apr;10(2):79-161. doi: 10.1089/bio.2012.1022.
5
Molecular medicine ireland guidelines for standardized biobanking.爱尔兰分子医学标准化生物样本库指南。
Biopreserv Biobank. 2010 Mar;8(1):3-63. doi: 10.1089/bio.2010.8101.
6
Ethical challenges in biobanking: moving the agenda forward in India.生物样本库中的伦理挑战:推动印度的议程向前发展。
Indian J Med Ethics. 2014 Apr 1;11(2):79-88. doi: 10.20529/IJME.2014.022.
7
Toward a common language for biobanking.迈向生物样本库的通用语言。
Eur J Hum Genet. 2015 Jan;23(1):22-8. doi: 10.1038/ejhg.2014.45. Epub 2014 Apr 9.
8
Predictive, Preventive and Personalised Medicine as the hardcore of 'Horizon 2020': EPMA position paper.预测医学、预防医学和个性化医学作为“地平线 2020”的核心:EPMA 立场文件。
EPMA J. 2014 Apr 7;5(1):6. doi: 10.1186/1878-5085-5-6.
9
Biobanking in a constantly developing medical world.在不断发展的医学领域中的生物样本库。
ScientificWorldJournal. 2013 Sep 23;2013:343275. doi: 10.1155/2013/343275. eCollection 2013.
10
Biobanking past, present and future: responsibilities and benefits.生物库的过去、现在和未来:责任与利益。
AIDS. 2013 Jan 28;27(3):303-12. doi: 10.1097/QAD.0b013e32835c1244.